From: National governance of de-implementation of low-value care: a qualitative study in Sweden
Theme | Subtheme | Stakeholders describing being involved in the activity* |
---|---|---|
Recommendations | Do-not-do recommendations | NBHW, Medical Products Agency |
Ranking of the priority of recommendations | NBHW | |
Removal of outdated recommendations | NBHW, Medical Products Agency | |
Recommendations after inspections | Health and Social Care Inspectorate | |
Priority support | Swedish Agency for Health Technology Assessment and Assessment of Social Services | |
Health technology assessment | Swedish Agency for Health Technology Assessment and Assessment of Social Services | |
Control over pharmaceutical products | Withdrawal of pharmaceutical products | Medical Products agency |
Removal of the substitution of medicines | Dental and Pharmaceutical Benefits Agency | |
Denial of price increase requests | Dental and Pharmaceutical Benefits Agency | |
National system for knowledge management | SALAR |